Figure 6
Intracellular daunorubicin concentration following treatment with free drugs versus CPX-351 liposomal formulation. Data available only as a single 24-h treatment.
Figure 6 | Scientific Reports
Intracellular daunorubicin concentration following treatment with free drugs versus CPX-351 liposomal formulation. Data available only as a single 24-h treatment.
